Pomalidomide plus bortezomib and dexamethasone for newly diagnosed multiple myeloma with renal impairment: Randomized phase II study (POM-MM-003)

Med · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles